Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 181-190 of 11861

Edit search filters
  1. A Study of Cerebral Perfusion with tDCS in Chronic Hypoperfusion

  2. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial

    Jacksonville, FL, Rochester, MN

  3. CLN-049 In Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) Or Myelodysplastic Syndrome (MDS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. App-Based Optimization Of Long-Term CPAP Adherence And Quality Of Life

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Study To Evaluate ARINA-1 In The Prevention Of Bronchiolitis Obliterans Progression In Participants With Bilateral Lung Transplant

    Rochester, MN

  6. A Study To Evaluate The Efficacy And Safety Of Ruxolitinib Cream In Participants With Cutaneous Lichen Planus

    Scottsdale/Phoenix, AZ

  7. A Phase 2b Study In Subjects With Alcoholic Hepatitis To Evaluate Safety And Efficacy Of DUR-928 Treatment

    Scottsdale/Phoenix, AZ

  8. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS

    Jacksonville, FL

  9. Wide Field OCT + AI For Positive Margin Rates In Breast Conservation Surgery

    Jacksonville, FL

  10. RP2/RP3 In Combination With Atezolizumab And Bevacizumab For The Treatment Of Patients With CRC

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer